Irisin ameliorates bone loss in ovariectomized mice

References

• Hernlund E, Svedbom A, Ivergård M, et al. Osteoporosis in the European Union: medical management, epidemiology and economic burden: a report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos 2013;8:136
   Web of Science ®Google Scholar
• Leslie WD, Morin SN. Osteoporosis epidemiology 2013: implications for diagnosis, risk assessment, and treatment. Curr Opin Rheumatol 2014;26:440–6
   PubMed Web of Science ®Google Scholar
• Boström P, Wu J, Jedrychowski MP, et al. A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 2012;481:463–8
   PubMed Web of Science ®Google Scholar
• Palermo A, Strollo R, Maddaloni E, et al. Irisin is associated with osteoporotic fractures independently of bone mineral density, body composition or daily physical activity. Clin Endocrinol 2015;82:615–19
   PubMed Web of Science ®Google Scholar
• Anastasilakis AD, Polyzos SA, Makras P, et al. Circulating irisin is associated with osteoporotic fractures in postmenopausal women with low bone mass but is not affected by either teriparatide or denosumab treatment for 3 months. Osteoporos Int 2014;25:1633–42
   PubMed Web of Science ®Google Scholar
• Ruchala M, Zybek A, Szczepanek-Parulska E. Serum irisin levels and thyroid function–newly discovered association. Peptides 2014;60:51–5
   PubMed Web of Science ®Google Scholar
• Lee MJ, Lee SA, Nam BY, et al. Irisin, a novel myokine is an independent predictor for sarcopenia and carotid atherosclerosis in dialysis patients. Atherosclerosis 2015;242:476–82
   PubMed Web of Science ®Google Scholar
• Kuloglu T, Aydin S, Eren MN, et al. Irisin: a potentially candidate marker for myocardial infarction. Peptides 2014;55:85–91
   PubMed Web of Science ®Google Scholar
• Lee HJ, Lee JO, Kim N, et al. Irisin, a novel myokine, regulates glucose uptake in skeletal muscle cells via AMPK. Mol Endocrinol 2015;29:873–81
   PubMed Web of Science ®Google Scholar
• Chen N, Li Q, Liu J, Jia S. Irisin, an exercise-induced myokine as a metabolic regulator: an updated narrative review. Diabetes Metab Res Rev 2016;32:51–9
   PubMed Web of Science ®Google Scholar
• Colaianni G, Cuscito C, Mongelli T, et al. Irisin enhances osteoblast differentiation in vitro. Int J Endocrinol 2014;2014:1–8
   Web of Science ®Google Scholar
• Colaianni G, Cuscito C, Mongelli T, et al. The myokine irisin increases cortical bone mass. Proc Natl Acad Sci USA 2015;112:12157–62
   PubMed Web of Science ®Google Scholar
• Qiao X, Nie Y, Ma Y, et al. Irisin promotes osteoblast proliferation and differentiation via activating the MAP kinase signaling pathways. Sci Rep 2016;6:18732
   PubMed Web of Science ®Google Scholar
• Colaianni G, Mongelli T, Cuscito C, et al. Irisin prevents and restores bone loss and muscle atrophy in hind-limb suspended mice. Sci Rep 2017;7:2811
   PubMed Web of Science ®Google Scholar
• Ma Y, et al. Irisin promotes proliferation but inhibits differentiation in osteoclast precursor cells. FASEB J 2018;32:5813–23
   Web of Science ®Google Scholar
• Khedgikar V, et al. A standardized phytopreparation from an Indian medicinal plant (Dalbergia sissoo) has antiresorptive and bone-forming effects on a postmenopausal osteoporosis model of rat. Menopause 2012;19:1336–46
   PubMed Web of Science ®Google Scholar
• Choudhary D, Kushwaha P, Gautam J, et al. Fast and long acting neoflavonoids dalbergin isolated from Dalbergia sissoo heartwood is osteoprotective in ovariectomized model of osteoporosis: osteoprotective effect of Dalbergin. Biomed Pharmacother 2016;83:942–57
   PubMed Web of Science ®Google Scholar
• Chung H-J, Kim WK, Oh J, et al. Anti-osteoporotic activity of harpagoside by upregulation of the BMP2 and Wnt signaling pathways in osteoblasts and suppression of differentiation in osteoclasts. J Nat Prod 2017;80:434–42
   PubMed Web of Science ®Google Scholar
• Stubelius A, Andersson A, Holmdahl R, et al. Ncf1 affects osteoclast formation but is not critical for postmenopausal bone loss. BMC Musculoskelet Disord 2016;17:464
   PubMed Web of Science ®Google Scholar
• Bahlous A, Kalai E, Hadj Salah M, Bouzid K, Zerelli L. Biochemical markers of bone remodeling: recent data of their applications in managing postmenopausal osteoporosis. Tunis Med 2006;84:751–7
   PubMedGoogle Scholar
• Randell A, Sambrook PN, Nguyen TV, et al. Direct clinical and welfare costs of osteoporotic fractures in elderly men and women. Osteoporosis Int 1995;5:427–32
   PubMed Web of Science ®Google Scholar
• Mori T, Okimoto N, Sakai A, et al. Climbing exercise increases bone mass and trabecular bone turnover through transient regulation of marrow osteogenic and osteoclastogenic potentials in mice. J Bone Miner Res 2003;18:2002–9
   PubMed Web of Science ®Google Scholar
• Hoshi A, Watanabe H, Chiba M, Inaba Y. Bone density and mechanical properties in femoral bone of swim loaded aged mice. Biomed Environ Sci 1998;11:243–50
   PubMed Web of Science ®Google Scholar
• Huang TH, Lin SC, Chang FL, et al. Effects of different exercise modes on mineralization, structure, and biomechanical properties of growing bone. J Appl Physio 2003;95:300–7
   PubMed Web of Science ®Google Scholar
• Khosla S, Melton LJ, 3rd, Riggs BL. The unitary model for estrogen deficiency and the pathogenesis of osteoporosis: is a revision needed? J Bone Miner Res 2011;26:441–51
   PubMed Web of Science ®Google Scholar
• Bouxsein ML, Myers KS, Shultz KL, et al. Ovariectomy-induced bone loss varies among inbred strains of mice. J Bone Miner Res 2005;20:1085–92
   PubMed Web of Science ®Google Scholar
• Wang T, Liu Q, Zhou L, et al. Andrographolide inhibits ovariectomy-induced bone loss via the suppression of RANKL signaling pathways. IJMS 2015;16:27470–81
   Google Scholar
• Li W, Wang K, Liu Z, Ding W. HIF-1alpha change in serum and callus during fracture healing in ovariectomized mice. Int J Clin Exp Pathol 2015;8:117–26
   PubMed Web of Science ®Google Scholar
• Spilmont M, Léotoing L, Davicco M-J, et al. Pomegranate peel extract prevents bone loss in a preclinical model of osteoporosis and stimulates osteoblastic differentiation in vitro. Nutrients 2015;7:9265–84
   PubMed Web of Science ®Google Scholar
• Shuai B, Shen L, Yang Y, et al. Assessment of the impact of zoledronic acid on ovariectomized osteoporosis model using micro-CT scanning. PLoS One 2015;10:e0132104
   PubMed Web of Science ®Google Scholar
• Akbar MA, Cao JJ, Lu Y, et al. Alpha-1 antitrypsin gene therapy ameliorates bone loss in ovariectomy-induced osteoporosis mouse model. Hum Gene Ther 2016;27:679–86
   PubMed Web of Science ®Google Scholar
• Valladares RD, Nich C, Zwingenberger S, et al. Toll-like receptors-2 and 4 are overexpressed in an experimental model of particle-induced osteolysis. J Biomed Mater Res 2014;102:3004–11
   Web of Science ®Google Scholar
• Glatt V, Canalis E, Stadmeyer L, Bouxsein ML. Age-related changes in trabecular architecture differ in female and male C57BL/6J mice. J Bone Miner Res 2007;22:1197–207
   PubMed Web of Science ®Google Scholar
• Ferguson VL, Ayers RA, Bateman TA, Simske SJ. Bone development and age-related bone loss in male C57BL/6J mice. Bone 2003;33:387–98
   PubMed Web of Science ®Google Scholar
• Rahman S, Lu Y, Czernik PJ, et al. Inducible brown adipose tissue, or beige fat, is anabolic for the skeleton. Endocrinology 2013;154:2687–701
   PubMed Web of Science ®Google Scholar
• Zhang Y, Li R, Meng Y, et al. Irisin stimulates browning of white adipocytes through mitogen-activated protein kinase p38 MAP kinase and ERK MAP kinase signaling. Diabetes 2014;63:514–25
   PubMed Web of Science ®Google Scholar
• Dalle Carbonare L, Giannini S. Bone microarchitecture as an important determinant of bone strength. J Endocrinol Invest 2004;27:99–105
   PubMed Web of Science ®Google Scholar
• Mirzaali MJ, Libonati F, Ferrario D, et al. Determinants of bone damage: an ex-vivo study on porcine vertebrae. PLoS One 2018;13:e0202210
   PubMed Web of Science ®Google Scholar
• Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med 1993;94:646–50
   PubMed Web of Science ®Google Scholar
• Kameda T, Mano H, Yuasa T, et al. Estrogen inhibits bone resorption by directly inducing apoptosis of the bone-resorbing osteoclasts. J Exp Med 1997;186:489–95
   PubMed Web of Science ®Google Scholar
• Guangtao FU, et al. Ovariectomy on 12-week-old mature female C57/BL6J mice is the appropriate timing of animal model for postmenopausal osteoporosis. (2018). https://kns.cnki.net/KCMS/detail/detail.aspx?dbcode=CJFQ&dbname=CJFDLAST2018&filename=ZGZS201805006&v=MDQyNTNDdmxXcnpPUHlyUmZiRzRIOW5NcW85RllvUjhlWDFMdXhZUzdEaDFUM3FUcldNMUZyQ1VSN3FmWStadUY=
   Google Scholar